Erleada

Erleada Indications/Uses

apalutamide

Manufacturer:

Janssen

Distributor:

Zuellig Pharma
Full Prescribing Info
Indications/Uses
ERLEADA is indicated in adult men for the treatment of non-metastatic castration-resistant prostate cancer (NM-CRPC) who are at high risk of developing metastatic disease (see Pharmacology: Pharmacodynamics under Actions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in